Revisions for Rifampin

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
07-27-21 by [email protected]current revision
07-26-21 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
07-10-20 by [email protected]
04-22-20 by ucsf_admin
04-22-20 by ucsf_admin

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication Dosing Notes
Mycobacterial infections 600 mg IV/PO q24h

 

No renal dose adjustment

Prosthetic device infections 300 mg IV/PO q12h
Endocarditis 300 mg IV/PO q8h

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication Dosing Notes
Mycobacterial infections 600 mg IV/PO q24h

 

No adjustment in hemodialysis

Prosthetic device infections 300 mg IV/PO q12h
Endocarditis 300 mg IV/PO q8h

Dialysis Notes

Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min.  For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.

Review medications for potential drug interactions.

References: